Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merus
Biotech
Bicara CEO: ASCO data resonate more with 'people that matter'
"Our data is resonating far more with the people that matter, which are the head and neck oncologists," Bicara's CEO told Fierce.
Gabrielle Masson
Jun 2, 2025 4:26pm
ASCO: Chasing Merus, Bicara shares 2-year HNSCC survival data
Jun 1, 2025 3:36pm
Merus hails 'unprecedented' survival on solid tumor bispecific
May 23, 2025 7:35am
Merus touts cancer drug's strong profile with new data drop
Dec 2, 2024 11:59am
FDA delays decision on Merus' first-in-class cancer drug
Nov 5, 2024 9:14am
Merus cancer bispecific lives up to investors' expectations
May 24, 2024 8:53am
